Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: S-8, Date: 2012-04-27
Original SEC Filing: Click here

---

Webplus: SKBI/20120427/S-8_1/1/000.htm SEC Original: v310001_s8.htm

---

---

Webplus: SKBI/20120427/S-8_1/2_EX-5.1/000.htm SEC Original: v310001_ex5-1.htm
[Cozen O’Connor Letterhead] April 27, 2012 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re: Registration Statement on Form S-8 In rendering this opinion, we have examined: (i) the Articles of Incorporation and By-laws of the Company, each as presently in effect; (ii) resolutions of the Company’s Board of

---

---

Webplus: SKBI/20120427/S-8_1/3_EX-23.1/000.htm SEC Original: v310001_ex23-1.htm
Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-8 of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended December 31, 2011. Sherman Oaks, California

---

Company Information:

Ticker: SKBI, Company: SKYSTAR BIO-PHARMACEUTICAL CO, Type: S-8, Date: 2012-04-27CIK: 0001076939, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
RM 10601, JIEZUO PLAZA, NO. 4, FENGHUI ROAD SOUTH, GAOXIN DISTRICT
XIAN PROVINCE